• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates
Home » OrbiMed founder Isaly out after harassment allegations

OrbiMed founder Isaly out after harassment allegations

December 8, 2017 By Brad Perriello

OrbiMedOrbiMed founder and managing partner Sam Isaly yesterday stepped down in the wake of sexual harassment allegations lodged by several former employees of the healthcare hedge fund.

In a statement released last night, New York City-based OrbiMed said Isaly is leaving “pursuant to years-long succession planning discussions” and did not address the accusations from six women, first reported this week by STAT.

“I am extremely proud of what my distinguished partners and I have accomplished at OrbiMed and the difference we have made in the lives of patients worldwide,” Isaly said in the statement. “OrbiMed is a strong and vibrant company positioned for continued growth and this is a good time for me to pass the baton to the next generation of leaders.”

OrbiMed said it named a committee of Sven Borho, Carl Gordon and Jonathan Silverstein to take over Isaly’s managing partner duties.

Six former employees accused Isaly, a 72-year-old investor long revered in the biotech community for his ability to pick stocks, of routinely demeaning and harassing women with hardcore pornography and sex toys, STAT reported Dec. 5. Isaly has denied the allegations. The sixth accuser contacted the outlet after that story, requesting anonymity for fear of reprisal by the hedge fund.

Identified yesterday as Yanping Ren, the sixth accuser was a junior in college when she accepted a part-time internship at OrbiMed. Ren told STAT that Isaly routinely delivered vulgar and demeaning comments to women during her 18-month tenure, including remarks about their bodies. At least once a month, she said, she encountered women crying in the bathroom, “always related to something that happened in the office.”

“It was so normal in the company,” Ren told the site. “It was like a fact of life that everyone had to accept. Sam just did what he could get away with.”

The allegations mirror accusations leveled by five former OrbiMed employees about Isaly’s behavior. The story roiled Wall Street, prompting investment firm Eaton Vance to review its arrangement with OrbiMed, which provides it with investment advice, STAT reported earlier this week. OrbiMed said it’s hired an independent law firm to investigate the allegations.

Ren, now 29, told the outlet that she found Isaly’s conduct and its lack of consequences shocking. As her first experience in the world of finance, she assumed it was the norm.

“In college, you kind of hear about how crazy the workplace can be,” Ren said. “So I thought, ‘Oh this is just how it is.'”

Luckily her next job, at Vatera, was the opposite, where her boss was a woman and the culture was one of professionalism and respect, she said.

Although the fund did not respond to questions about Ren’s account, in a statement it said it “takes gender equality seriously and wishes to encourage a supportive work environment and equal opportunity for all employees.”

“When I read that statement, I found it quite funny,” Ren told STAT, “because it’s so far from the truth.”

Filed Under: Wall Street Beat Tagged With: OrbiMed, Venture Capital/Private Equity

In case you missed it

  • Precision Molding: Getting it Right the First Time
  • New medical device user fees agreement passes Congress
  • Invacare receives notice of noncompliance on NYSE share price listing rule
  • Philips shareholders approve new CEO
  • FDA clears next-gen deep learning MRI software from GE Healthcare
  • Analysts high on AtriCure following Converge AFib procedure update
  • Align Technology launches AI-powered home monitoring for Invisalign clear teeth aligners
  • How Medtronic designed the next generation of GI bleeding treatment
  • FDA clears Nexpowder endoscopic hemostasis system from Medtronic
  • This robotic capsule could deliver large-protein drugs like insulin
  • Olympus launches Thunderbeat surgical energy devices
  • 7 innovative digital health offerings to treat diabetes
  • Johnson & Johnson Vision launches overnight, intraocular lenses
  • Teleflex completes $170M Standard Bariatrics acquisition
  • OraSure Technologies receives $8.6M contract to develop next-gen Ebola test
  • Merit Medical Systems launches soft tissue biopsy system
  • Stryker launches Q Guidance system for spine surgery

RSS From Medical Design & Outsourcing

  • In vivo electroporation is an engineering solution for drug and gene delivery
    Why the new buzz about an old technique? Harness the potential of an existing technology for modern medicine. Daniel Friedrichs, Minnetronix Medical Reversible electroporation is the use of an electric field to open pores in a cell wall, allowing transport of drugs, DNA or other “cargo” into a cell — in particular, allowing delivery of… […]
  • FDA and VA Ventures Innovation Institute partner on new medical device testing tools
    The Department of Veterans Affairs’ VA Ventures Innovation Institute in Seattle will host up to a dozen FDA staffers in a new collaboration to develop and share new tools for medical device testing safety and efficacy. The agencies intend to provide developers of devices and new technology with off-the-shelf tools that can help streamline regulatory… […]
  • How Boston Scientific is managing labor shortages with cobots and Spanish
    Boston Scientific (NYSE: BSX) executives said two labor-shortage strategies are paying off in a big way for the medical device maker, which has around 41,000 employees across the globe. Collaborative robotics and Spanish-speaking shifts are helping Boston Scientific deal with labor shortages in the U.S. and elsewhere. That’s according to Global Operations EVP Brad Sorenson… […]
  • 6 power management considerations for developing and scaling smaller, smarter micromedical devices
    Supercharge every phase of micromedical device product development with these questions. Mitch Johnson, Intricon Some of the biggest considerations for designing, manufacturing and scaling today’s smaller, smarter medical innovations center on providing power to microelectronic systems. From mechanical functionality to data operations and wireless communications, effective power management drives continued device innovation. Addressing five fundamental… […]
  • Evonik, Coopmed agree on wound dressing distro deal
    Evonik announced today that it signed an agreement for medical technology company Coopmed to distribute the epicite wound dressing. Jena, Germany-based Evonik said Coopmed will distribute the epicite dressing made from biosynthetic cellulose exclusively to the German market for chronic wound care. Epicite represents part of the portfolio from JeNaCell, which Evonik acquired in 2021.… […]
  • Spartech hires Bosch VP Dan Gallo as chief operating officer
    Spartech today said it hired Dan Gallo as chief operating officer of the engineered thermoplastics and custom packaging manufacturer. Gallo started this month, according to his LinkedIn page. His career leading operations, supply chain and logistics functions spans more than three decades. He was most recently an operations VP at Robert Bosch. Before his time… […]
  • 3M launches Verify platform to spot counterfeit products
    3M (NYSE:MMM) announced today that it established a new 3M Verify platform to report potential counterfeit 3M products. The effort builds upon its anti-counterfeit efforts during the height of the COVID-19 pandemic. At the time, a number of sellers claimed to offer 3M respirators. Instead, many offered fake, defective and damaged N95 masks at inflated… […]
  • FDA will review fewer COVID-19 test EUA submissions
    The FDA is pushing COVID-19 test developers away from emergency use authorization (EUA) submissions in favor of more traditional pathways, the agency said today. The FDA said it intends to review “only a small subset” of new EUA submissions, encouraging test makers to seek regulatory approval through de novo classification or 510(k) clearance pre-market review… […]
  • Integra plans to shrink the C-suite after executive’s exit
    Integra Lifesciences (Nasdaq: IART) will eliminate the position of chief operating officer next week — though the office is already empty. Former COO Glenn Coleman’s last day at Integra was Friday, according to a separation agreement filed with the Securities and Exchange Commission that same day. Coleman was scheduled to start as the new EVP and… […]
  • Steris plans to build a new medical device testing facility
    Steris (NYSE: STE) plans to build a new packaging and microbiological testing facility for medical devices in Leipzig, Germany. The facility will offer packaging testing services such as accelerated and real-time aging, transportation and integrity testing. The new location will also offer microbiological testing in collaboration with the medical device manufacturer and sterilizer’s laboratory in… […]
  • 10 medical device startups you need to know
    Some of the most interesting medical device startups of 2022 are advancing a wide range of innovative medtech: robotics, catheter-delivered brain-computer interfaces and more. The editors here at Medical Design & Outsourcing and MassDevice are writing about medical device startups all the time. But there are some device companies starting out that have technologies that… […]

Primary Sidebar

DeviceTalks Weekly

September 30, 2022
How hospitals are forming closer ties with surgical robotics companies like Zimmer Biomet, Vicarious
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy